Analysis of the impact of minimally invasive esophagectomy on quality of life and functional prognosis in patients with esophageal squamous cell carcinoma: A retrospective comparative study
- PMID: 40448148
- PMCID: PMC12123707
- DOI: 10.1186/s13019-025-03485-9
Analysis of the impact of minimally invasive esophagectomy on quality of life and functional prognosis in patients with esophageal squamous cell carcinoma: A retrospective comparative study
Abstract
Background: Minimally invasive esophagectomy (MIE) has shown potential benefits in reducing postoperative complications and improving recovery for patients with esophageal squamous cell carcinoma (ESCC). This study aims to assess the effects of MIE on preoperative and postoperative quality of life and functional outcomes in ESCC patients.
Methods: Clinical data from 57 ESCC patients who underwent MIE were retrospectively analyzed. Baseline characteristics, including age, gender, BMI, TNM stage, smoking history, alcohol consumption, comorbidities, tumor location, differentiation, and lymph node metastasis, were collected. Postoperative quality of life scores, nutritional status, and functional outcomes were assessed. Paired t-tests and chi-square tests were used to compare preoperative and postoperative variables, while correlation analysis was conducted to evaluate associations between functional outcomes and quality of life.
Results: A total of 57 patients (41 males, 16 females; mean age: 67.61 ± 7.72 years) who underwent MIE were analyzed. Postoperative evaluation demonstrated significant improvements in quality of life scores across multiple dimensions, including physical symptoms (P = 0.006), emotional management (P = 0.013), role function (P = 0.013), cognitive function (P = 0.042), and social function (P = 0.021). Additionally, nutritional status improved postoperatively, with higher albumin levels (4.12 ± 0.34 g/dL vs. 3.78 ± 0.25 g/dL, P < 0.001) and reduced weight loss (1.98 ± 1.02 kg vs. 2.44 ± 1.12 kg, P = 0.026). Functional outcomes also showed significant improvements, including decreased dysphagia scores (3.45 ± 1.56 vs. 4.04 ± 0.31, P = 0.008), while cardiac physical activity and respiratory function remained stable (P > 0.05). Correlation analysis indicated significant associations between specific functional outcomes and quality of life (P < 0.05).
Conclusion: MIE improves quality of life, nutritional status, and functional outcomes in patients with esophageal squamous cell carcinoma, highlighting its potential benefits in postoperative recovery and patient well-being.
Trial registration: Not applicable.
Keywords: Esophageal squamous cell carcinoma; Functional outcomes; Minimally invasive esophagectomy; Quality of life.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of the First Affiliated Hospital of Anhui University of Chinese Medicine in accordance with regulatory and ethical guidelines pertaining to retrospective research studies. Informed consent was waived for this retrospective study due to the exclusive use of de-identified patient data, which posed no potential harm or impact on patient care. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Robot-assisted esophagectomy (RAE) versus conventional minimally invasive esophagectomy (MIE) for resectable esophageal squamous cell carcinoma: protocol for a multicenter prospective randomized controlled trial (RAMIE trial, robot-assisted minimally invasive Esophagectomy).BMC Cancer. 2019 Jun 21;19(1):608. doi: 10.1186/s12885-019-5799-6. BMC Cancer. 2019. PMID: 31226960 Free PMC article. Clinical Trial.
-
Comparisons between minimally invasive and open esophagectomy for esophageal cancer with cervical anastomosis: a retrospective study.J Cardiothorac Surg. 2020 Jun 8;15(1):128. doi: 10.1186/s13019-020-01182-3. J Cardiothorac Surg. 2020. PMID: 32513211 Free PMC article.
-
Minimally Invasive Esophagectomy Provides Better Short- and Long-Term Outcomes Than Open Esophagectomy in Locally Advanced Esophageal Cancer.Ann Surg Oncol. 2024 Sep;31(9):5748-5756. doi: 10.1245/s10434-024-15596-z. Epub 2024 Jun 19. Ann Surg Oncol. 2024. PMID: 38896227
-
Recent advances in minimally invasive esophagectomy for squamous esophageal cancer.Ann N Y Acad Sci. 2020 Dec;1482(1):113-120. doi: 10.1111/nyas.14461. Epub 2020 Aug 11. Ann N Y Acad Sci. 2020. PMID: 32783237 Review.
-
Robotic Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer: A Meta-analysis.Ann Surg. 2023 Jul 1;278(1):39-50. doi: 10.1097/SLA.0000000000005782. Epub 2022 Dec 20. Ann Surg. 2023. PMID: 36538615 Review.
References
-
- Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649–e582. - PubMed
-
- Waters JK, Reznik SI. Update on management of squamous cell esophageal Cancer. Curr Oncol Rep. 2022;24(3):375–85. - PubMed
-
- Pinotti HW, Cecconello I, De Oliveira MA. Transhiatal esophagectomy for esophageal cancer. Semin Surg Oncol. 1997;13(4):253–8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical